End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB

Huang, D; Wu, D; Wang, P; Wang, YL; Yuan, W; Hu, DQ; Hu, JJ; Wang, YQ; Tao, R; Xiao, F; Zhang, XP; Wang, XJ; Han, MF; Luo, XP; Yan, WM; Ning, Q

Luo, XP; Yan, WM; Ning, Q (通讯作者)，Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept & Inst Infect Dis, Wuhan, Peoples R China.;Luo, XP; Yan, WM; Ning, Q (通讯作者)，Natl Med Ctr Major Publ Hlth Events, Wuhan, Peoples R China.;Luo, XP; Yan, WM; Ning, Q (通讯作者)，State Key Lab Zoonot Dis, Wuhan, Peoples R China.

JOURNAL OF HEPATOLOGY, 2022; 77 (1): 42

Abstract

Background & Aims: Functional cure can be sustained in a proportion of patients with chronic hepatitis B (CHB) who lose hepatitis B surface antige......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索